What is Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP)?

Category: Prescription Drugs


See also: Cisplatin Cyclophosphamide Etoposide

Dexamethasone-cyclophosphamide-etoposide-cisplatin, also known as DCEP, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents cyclophosphamide, etoposide, and cisplatin along with dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP)

Side effect Patients
Feeling of heart pounding 1
Hearing loss in left ear 1

Why patients stopped taking Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP)

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped taking Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP)


Stopped taking Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP)

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for Dexamethasone-cyclophosphamide-etoposide-cisplatin (DCEP).